Serotonin, cerebral blood flow, and cerebral metabolic rate in geriatric major depression and normal aging (Q73196400)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10567727%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

review article

1 reference

title

Serotonin, cerebral blood flow, and cerebral metabolic rate in geriatric major depression and normal aging (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10567727%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Nobler MS

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10567727%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Mann JJ

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10567727%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sackeim HA

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10567727%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10567727%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10567727%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10567727%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

250-263

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10567727%20AND%20SRC:MED&resulttype=core&format=json

Low brain uptake of L-[11C]5-hydroxytryptophan in major depression: a positron emission tomography study on patients and healthy volunteers

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

'Vascular depression' hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Biochemical evidence of selective nerve cell changes in the normal ageing human and rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Age stability of human brain 5-HT terminals studied with [3H]paroxetine binding

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Effect of aging in human cortical pre- and postsynaptic serotonin binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Aging and 3H-paroxetine binding in rat brain: effect of imipramine and tetrahydroacridine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Serotonin selectively attenuates glutamate-evoked activation of noradrenergic locus coeruleus neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

123I-5-I-R91150, a new single-photon emission tomography ligand for 5-HT2A receptors: influence of age and gender in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Reduction of prefrontal cortex glucose metabolism common to three types of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

The anatomy of melancholia--focal abnormalities of cerebral blood flow in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Late-life suicide: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Frontal and parietal metabolic disturbances in unipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Accuracy and reproducibility of brain and tissue volumes using a magnetic resonance segmentation method

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Subcortical hyperintensity on magnetic resonance imaging: a comparison of normal and depressed elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Serotonin in the regulation of brain microcirculation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Fluoxetine effects on cerebral glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Cerebrovascular nerves in old rats show reduced accumulation of 5-hydroxytryptamine and loss of nerve fibres

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Influence of ascending serotonergic pathways on glucose use in the conscious rat brain. II. Effects of electrical stimulation of the rostral raphé nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

SPECT imaging of serotonin2 receptors in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Autoradiographic analysis of serotonin 5-HT1A receptor binding in the human brain postmortem: effects of age and alcohol

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Functional neuroimaging studies of depression: the anatomy of melancholia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

A functional anatomical study of unipolar depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Dose- and time-dependent effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), a serotonergic 5-HT2 receptor agonist, on local cerebral glucose metabolism in awake rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Time courses of behavioral and regional cerebral metabolic responses to different doses of meta-chlorophenylpiperazine in awake rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Measuring the neuromodulatory effects of drugs in man with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Depression and the course of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

The effects of age, gender, and season on serotonergic function in healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Neurochemistry and paroxetine response in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Aging associated changes in serotoninergic and dopaminergic pre- and postsynaptic neurochemical markers in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Local cerebral glucose utilisation following indoleamine- and piperazine-containing 5-hydroxytryptamine agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Autoradiographic analysis of [3H]ketanserin binding in the human brain postmortem: effect of suicide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

A double-blind trial of fluoxetine, 20 mg, and placebo in out-patients with DSM-III-R major depression and melancholia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Subcortical hyperintensities on magnetic resonance imaging: Clinical correlates and prognostic significance in patients with severe depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Effects of m-chlorophenylpiperazine on regional brain glucose utilization: a positron emission tomographic comparison of alcoholic and control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Age differences in intercorrelations between regional cerebral metabolic rates for glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Decreased cerebral 5-HT1A receptors during ageing: reversal by Ginkgo biloba extract (EGb 761).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Stability of cerebral blood flow and oxygen metabolism during normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

The detection of age-related decrease of dopamine D1, D2 and serotonin 5-HT2 receptors in living human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Structure and function of the brain serotonin system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

CSF 5-HIAA and HVA concentrations in elderly depressed patients who attempted suicide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Modulation of cortical neuronal activity by a serotonergic agent: a PET study in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Differential patterns of local cerebral glucose utilization in response to 5-hydroxytryptamine agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

MRI-defined vascular depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Imaging of serotonin and dopamine transporters in the living human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Regional cerebral glucose metabolism in late-life depression and Alzheimer disease: a preliminary positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Evidence for a decline with age in behavioral responsivity to the serotonin agonist, m-chlorophenylpiperazine, in healthy human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Reduction of cerebral blood flow in older depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Biological parameters in major depression: effects of paroxetine, viloxazine, moclobemide, and electroconvulsive therapy. Relation to early clinical outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

The neurobiology of suicide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Positron Emission Tomographic Imaging of Serotonin Activation Effects on Prefrontal Cortex in Healthy Volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Regional cerebral oxygen consumption, blood flow, and blood volume in healthy human aging

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

5-Hydroxytryptamine-sensitive [3H]imipramine binding of protein nature in the human brain. II. Effect of normal aging and dementia disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Serotonin-2 binding sites in human frontal cortex and hippocampus. Selective loss of S-2A sites with age.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Effect of age on human brain serotonin (S-1) binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Decreases in regional cerebral blood flow with normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Cerebrovascular and functional consequences of 5-HT1A receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Effects of age and gender on CNS serotonergic responsivity in normal adults

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Serotonin, memory, and the aging brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Correction of PET data for partial volume effects in human cerebral cortex by MR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Neuromodulation of frontal and temporal cortex by intravenous d-fenfluramine: an [15O]H2O PET study in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

No effect of depression on [(15)O]H2O PET response to intravenous d-fenfluramine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Neuroanatomical structures involved in the action of the 5-HT3 antagonist ondansetron: a 2-deoxyglucose autoradiographic study in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Endocrine and amine responses to D,L-fenfluramine in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageing

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

The metabolic topography of normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Scaled subprofile model: a statistical approach to the analysis of functional patterns in positron emission tomographic data

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

The dopamine and serotonin systems during aging in human and rodent brain. A brief review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Vulnerability to aging in the rat serotonergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Cerebral blood flow and metabolism in late-life depression and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Selective decline of 5-HT1A receptor binding sites in rat cortex, hippocampus and cholinergic basal forebrain nuclei during aging

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Serotonergic mechanisms in brains of suicide victims

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Apparent absence of aging and gender effects on serotonin 1A receptors in human neocortex and hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Do the endocrine and subjective effects of d-fenfluramine predict response to selective serotonin reuptake inhibitors?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Relationship Between Blood Serotonergic Variables, Melancholic Traits, and Response to Antidepressant Treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Effects of healthy aging on the regional cerebral metabolic rate of glucose assessed with statistical parametric mapping.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Diminished serotonin-mediated prolactin responses in nondepressed stroke patients compared with healthy normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Regional cerebral blood flow in mood disorders: IV. Comparison of mania and depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Child and adolescent mood disorders--experience with serotonin-based therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Regional cerebral blood flow in mood disorders. I. Comparison of major depressives and normal controls at rest

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Intravenous clomipramine challenge in obsessive-compulsive disorder: predicting response to oral therapy at eight weeks.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Neuroendocrine effects of a 20-mg citalopram infusion in healthy males. A placebo-controlled evaluation of citalopram as 5-HT function probe

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Elevated density of [3H]imipramine binding in aged human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

The alteration of serotonin binding sites in aged human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Quantitative PET analysis of regional cerebral blood flow and glucose and oxygen metabolism in response to fenfluramine in living porcine brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

The functional neuroanatomy of mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Initial increase of plasma serotonin: a biological predictor for the antidepressant response to clomipramine?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Imaging of the serotonergic system: interactions of neuroanatomical and functional abnormalities of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Analysis of the Hamilton Depression Rating Scale factors from a double-blind, placebo-controlled trial of fluoxetine in geriatric major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Regulation of cortical blood flow by the dorsal raphe nucleus: topographic organization of cerebrovascular regulatory regions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Ultrastructure of serotonin-immunoreactive terminals in the core and shell of the rat nucleus accumbens: cellular substrates for interactions with catecholamine afferents

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Localization of serotonin 5-HT2 receptors in living human brain by positron emission tomography using N1-([11C]-methyl)-2-Br-LSD.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Effects of Age on Dopamine and Serotonin Receptors Measured by Positron Tomography in the Living Human Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Effect of the 5-HT1A receptor agonist ipsapirone on the local cerebral glucose utilization of the rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Serotonergic ligand binding in aging brain of experimental animals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

Sensitivity of Cerebral Glucose Metabolism to Age, Gender, Brain Volume, Brain Atrophy, and Cerebrovascular Risk Factors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0173%2899%2900019-3

7 January 2021

10.1016/S0165-0173(99)00019-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10567727%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference